Pacira Pharmaceuticals, Inc.

10578 Science Center Drive
Suite 125
San Diego, CA 92121
(858) 625 2424

5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560

TAKING CARE OF PATIENTS, TODAY AND TOMORROW

SEC Filings

10-K
PACIRA PHARMACEUTICALS, INC. filed this Form 10-K on 03/01/2017
Entire Document
 << Previous Page | Next Page >>
PACIRA PHARMACEUTICALS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 12—NET INCOME (LOSS) PER SHARE (Continued)


 
Year Ended December 31,
 
2016
 
2015
 
2014
Numerator:
 
 
 
 
 
Net income (loss)
$
(37,949
)
 
$
1,856

 
$
(13,716
)
Denominator:
 
 
 
 
 
Weighted average common shares outstanding—basic
37,236

 
36,540

 
35,299

Computation of diluted securities:
 
 
 
 
 
Dilutive effect of stock options

 
1,638

 

Dilutive effect of RSUs

 
3

 

Dilutive effect of conversion premium on the Notes

 
3,113

 

Dilutive effect of warrants

 
6

 

Dilutive effect of ESPP

 
1

 

Weighted average common shares outstanding—diluted
37,236

 
41,301

 
35,299

Net income (loss) per share:
 
 
 
 
 
Basic net income (loss) per common share
$
(1.02
)
 
$
0.05

 
$
(0.39
)
Diluted net income (loss) per common share
$
(1.02
)
 
$
0.04

 
$
(0.39
)
The following outstanding stock options, RSUs, conversion premium on the Notes, warrants and ESPP purchase options are antidilutive in the periods presented (in thousands):
 
Year Ended December 31,
 
2016
 
2015
 
2014
Weighted average number of stock options
4,482

 
1,891

 
3,534

Weighted average number of RSUs
290

 
99

 

Conversion premium on the Notes
2,022

 

 
2,483

Weighted average number of warrants
1

 

 
21

Weighted average ESPP purchase options
21

 
8

 
1

     Total
6,816

 
1,998

 
6,039

NOTE 13—INCOME TAXES
Income (loss) before income taxes and the related tax expense is as follows (in thousands):
 
Year Ended December 31,
 
2016
 
2015
 
2014
Income (loss) before income taxes:
 
 
 
 
 
   Domestic
$
(36,339
)
 
$
3,760

 
$
(13,271
)
   Foreign
(1,505
)
 
(1,640
)
 
(272
)
      Total income (loss) before income taxes
$
(37,844
)
 
$
2,120

 
$
(13,543
)
 
 
 
 
 
 
Current taxes:
 
 
 
 
 
   Federal
$
11

 
$
92

 
$

   State
94

 
172

 
173

      Total income tax expense
$
105

 
$
264

 
$
173

The tax provision of $0.1 million and $0.2 million for the years ended December 31, 2016 and 2014, respectively, is principally the result of minimum state taxes. The tax provision of $0.3 million for the year ended December 31, 2015 is the result of the federal alternative minimum tax and state taxes.

F- 27

 << Previous Page | Next Page >>

Contact Investor Relations:
Susan Mesco
(973) 451-4030
Susan.Mesco@pacira.com


IHI/NPSF Project Seeks to Improve the Assessment and Management of Acute Pain
Click here for more...